With 20 blockbuster launches, Novartis CEO Narasimhan hopes to overcome a $9 billion patent cliff.
Summary- Leading the charge for Narasimhan’s blockbuster launch list is cholesterol therapy Leqvio, which awaits an FDA decision on Jan. 1. Others…
Summary- Leading the charge for Narasimhan’s blockbuster launch list is cholesterol therapy Leqvio, which awaits an FDA decision on Jan. 1. Others…
Synopsis : Zydus Cadila’s COVID-19 vaccine ZyCoV-D will be initially introduced in seven States including Bihar, Jharkhand, Maharashtra, Punjab, Tamil Nadu, Uttar…
Summary – A U.S. District Court has ruled in favor of Amgen in a patent litigation case involving the drug Enbrel, preventing…
Summary: In a split decision, the U.S. Court of Appeals for the Federal Circuit affirmed a West Virginia federal court’s ruling that…
SYNOPSIS: New 510(k) clearance expands the use of MammoScreen from 2D to 3D mammography, opening up the entire breast cancer screening market.…
KEYPOINTS: QIAGEN (QGEN) and DiaSorin said that the U.S. Food and Drug Administration has approved the LIAISON QuantiFERON-TB Gold Plus assay for…
Noticing the unknown plant that grew abundantly in the backyard of my ancestral house, I used to wonder what it was used…
The FDA has approved CYTALUX for adult patients with ovarian cancer as an adjunct for intraoperative identification of malignant lesions, according to…
KEYPOINTS: The FDA has granted orphan drug designation (ODD) to CT120 for the treatment of acute lymphoblastic leukemia, a novel chimeric antigen…
HIGHLIGHTS: The proposal for an Ordinance that regulates the rite of selection of processes for registration of pesticides and related products with…